Company Filing History:
Years Active: 2025
Title: Linda Black - Innovator in Regenerative Medicine
Introduction
Linda Black is a pioneering inventor based in San Diego, CA. She has made significant contributions to the field of regenerative medicine, particularly through her innovative research on uterine-derived regenerative cell compositions. Her work focuses on developing treatments for various diseases affecting canines and felines.
Latest Patents
Linda Black holds a patent for "Uterine-derived regenerative cell compositions and uses thereof." This patent describes heterogeneous cell compositions derived from canine or feline uterine tissue. The compositions include a mixture of mesenchymal progenitor cells and epithelial progenitor cells. These cell compositions are intended for use as autologous or allogeneic treatments for diseases such as chronic kidney disease, atopic dermatitis, immune-mediated arthritis, hepatitis, liver disease, inflammatory bowel disease, osteoarthritis, intravertebral disc disease, keratoconjunctivitis sicca (dry eye), pancreatitis, fibrosis, sclerosis, amyloidosis, immune-mediated polyarthritis, and wounds in canines and felines.
Career Highlights
Linda Black is associated with Gallant Pet, Inc., where she continues to advance her research and innovations in veterinary medicine. Her work has the potential to improve the quality of life for pets suffering from various health conditions.
Collaborations
Linda collaborates with notable colleagues, including Shelly J Zacharias and Theodore T Sand, who contribute to her research efforts and the development of new treatments.
Conclusion
Linda Black's innovative work in regenerative medicine showcases her commitment to improving animal health through scientific advancements. Her contributions are paving the way for new treatment options for pets in need.